# Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)

> **NCT01625845** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 36 (actual)

## Conditions studied

- Major Depressive Disorder
- Depression
- Depressive Symptoms
- Cardiovascular Disease (CVD)
- Coronary Artery Disease (CAD)
- Heart Disease

## Interventions

- **DRUG:** Pentoxifylline
- **OTHER:** Placebo
- **BEHAVIORAL:** Standard Treatment

## Key facts

- **NCT ID:** NCT01625845
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01625845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01625845, "Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01625845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*